We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > AIVITA

News List

Cancer vaccine shows promise in glioblastoma trial europeanpharmaceuticalreview
June 11, 2021
Personalised cancer vaccine increases progression free survival by approximately 50 percent in patients with newly diagnosed glioblastoma.
AIVITA Completes Phase 1 Study of Personalized COVID-19 Vaccine Candidate americanpharmaceuticalreview
March 02, 2021
AIVITA Biomedical announced the completion of a Phase 1 clinical study in Indonesia of its personalized vaccine candidate, AV-COVID-19, for the novel coronavirus (SARS-CoV-2).
AIVITA Biomedical's Glioblastoma Trial Shows Improved Progression Free Survival americanpharmaceuticalreview
December 02, 2020
AIVITA Biomedical announced data from its multi-center Phase 2 clinical trial of its personalized cancer vaccine, AV-GBM-1, in patients with newly diagnosed glioblastoma (GBM).
AIVITA Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial americanpharmaceuticalreview
February 26, 2019
AIVITA Biomedical announced its first patient has completed treatment in its multi-center Phase 2 ROOT OF CANCER ovarian cancer trial.....
AIVITA Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial americanpharmaceuticalreview
November 20, 2018
AIVITA Biomedical has dosed the first two patients in its Phase 2 clinical trial in patients with newly diagnosed gliobl